← All organizations
Highest phase reached
Phase 2
First clinical trial
May 3, 2018Last known activity
Jul 4, 2023
Timeline
2010s
- Jul 1, 2015
Hrain Biotechnology Co., Ltd.— Founded
Drugs by trial phase (11 distinct, 15 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06045091Lead sponsorEarly Phase 1Jul 4, 2023
- NCT05651191Lead sponsorEarly Phase 1Oct 21, 2022
- NCT05651178Lead sponsorEarly Phase 1Aug 12, 2022
- NCT05223686Lead sponsorPhase 1Feb 10, 2022
- NCT05302648Lead sponsorEarly Phase 1Feb 9, 2022
- NCT06760260Lead sponsorEarly Phase 1Jan 26, 2022
- NCT05436223Lead sponsorPhase 2Aug 9, 2021
- NCT03879382Lead sponsorPhase 1Jul 31, 2019
- NCT03943472Lead sponsorEarly Phase 1Jul 31, 2019
- NCT03814447CollaboratorEarly Phase 1Jun 30, 2019
- NCT03799913CollaboratorEarly Phase 1Apr 10, 2019
- NCT03798509Lead sponsorPhase 1Mar 13, 2019
- NCT03720457Lead sponsorPhase 1Nov 13, 2018
- NCT03706547CollaboratorPhase 1Oct 30, 2018
- NCT04303520CollaboratorPhase 1May 3, 2018
Details
- Founded
- Shanghai, CN Jul 1, 2015
- Last known activity
- Jul 4, 2023